WELCOME TO G-FINDER
The G-FINDER survey tracks global public, private, and philanthropic investment into product research and development (R&D) for neglected diseases. These are diseases that predominantly affect developing countries and for which products are needed but there is insufficient commercial incentive to stimulate R&D.
Additionally, the survey tracks investment into product R&D for emerging infectious diseases (EIDs). The list of diseases included is based on the priority pathogens identified in the WHO R&D Blueprint.
The survey includes R&D of drugs, vaccines, diagnostics, vector control products and microbicides, from basic research through to post-registration studies.
G-FINDER Reports
Survey results are published and launched as yearly G-FINDER reports.
G-FINDER reports from previous years:
2017. Neglected Disease Research & Development: Reflecting on a decade of global investment
2016. Neglected Disease Research & Development: A pivotal moment for global health
2015. Neglected Disease Research & Development: The Ebola effect
2014. Neglected Disease Research & Development: Emerging trends
2013. Neglected Disease Research & Development: The public divide
2012. Neglected Disease Research & Development: A five year review
2011. Neglected Disease Research & Development: Is innovation under threat?
2010. Neglected Disease Research & Development: Is the global financial crisis changing R&D
2009. Neglected Disease Research & Development: New times, new trends
2008. Neglected Disease Research & Development: How much are we really spending?
G-FINDER Public Search Tool
The underlying data behind the G-FINDER reports is also made freely available via the G-FINDER public search tool. Confidential industry data is aggregated and anonymised.